Home Community Cutting-edge technology for lung biopsies and improved early cancer detection

Cutting-edge technology for lung biopsies and improved early cancer detection

0
Cutting-edge technology for lung biopsies and improved early cancer detection

In our commitment to advancing patient care, I’m thrilled to introduce the newest breakthrough in lung biopsy technology, the Intuitive Ion Navigational Bronchoscopy.

This cutting-edge system allows our doctors at NCH to exactly goal and sample lung nodules without invasive surgery or needle punctures. The good thing about this technology is finding cancers within the lungs where curative therapy might be began earlier.

Paul Hiltz

Within the U.S., the common five-year survival rate for all stages of non-small cell lung cancer (essentially the most common kind) is 23%, compared with 90% for all stages of breast cancer and 98% for all stages of prostate cancer. One reason for the lower survival rate is that about 72% of patients diagnosed with lung cancer have nonlocalized disease, meaning the cancer is detected after it has spread beyond the initial tumor.

LEAVE A REPLY

Please enter your comment!
Please enter your name here